Skip to main content
logo
Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
4.960
+0.320 (6.90%)
At close: Nov 21, 2025, 4:00 PM EST
4.990
+0.030 (0.60%)
After-hours: Nov 21, 2025, 6:42 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Oncolytic Immunotherapies
8.00K
Log In
Log In
Oncolytic Immunotherapies Growth
-95.29%
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
United States
8.00K
Log In
Log In
United States Growth
-95.29%
Log In
Log In